pathogen detection
Spain's DeepUll Raises €50M in Oversubscribed Series C Financing Round
The funds will help the company finalize clinical trials for its automated molecular rapid sepsis pathogen identification and antimicrobial susceptibility testing system.
Oxford Nanopore Technologies, Cepheid Partner for Automated Pathogen Sequencing
The two firms aim to develop an end-to-end solution to simplify the nanopore sequencing workflow and eventually enable expanded clinical use.
Investigators found that they could increase CNS infection diagnoses by using metagenomic next-generation sequencing to test cerebrospinal fluid samples.
Diagnostics firm QuantaMatrix plans to commercialize the technologies with an automated instrument for pathogen detection, identification, and resistance profiling.
Day Zero Diagnostics Aiming to Bring Whole-Genome Sequencing Pathogen ID/AST to Clinical Labs
Premium
The firm intends to use new funding to move its platform into the clinical trial stage in the pursuit of an FDA-regulated IVD product.